Calmare Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Cash & Short Term Investments
74.30
57.00
5.70
49.80
12.60
Total Accounts Receivable
216.40
143.30
2.30
33.10
3.40
Inventories
4,360.20
4,278.20
4,118.20
4,028.20
3,838.20
Other Current Assets
78.70
65.20
253.10
58.00
7.90
Total Current Assets
4,729.60
4,543.70
4,379.40
4,169.10
3,862.00
Net Property, Plant & Equipment
26.80
7.60
35.60
23.70
7.20
Total Investments and Advances
-
-
15.00
15.00
-
Other Assets
15.00
15.00
-
-
15.00
Total Assets
4,771.40
4,566.30
4,430.00
4,207.90
3,884.20
ST Debt & Current Portion LT Debt
1,310.00
2,488.70
2,978.00
4,226.20
5,916.90
Accounts Payable
5,987.60
4,875.80
5,528.50
6,077.80
6,269.20
Other Current Liabilities
1,277.90
3,146.30
3,605.20
4,249.70
5,510.20
Total Current Liabilities
8,575.50
10,510.80
12,111.70
14,553.70
17,696.30
Long-Term Debt
225.00
-
56.70
67.90
-
Total Liabilities
8,800.50
10,510.80
12,168.40
14,621.70
17,696.30
Common Equity (Total)
4,089.70
6,005.10
7,799.00
10,474.50
13,872.70
Total Shareholders' Equity
4,029.10
5,944.50
7,738.30
10,413.80
13,812.00
Total Equity
4,029.10
5,944.50
7,738.30
10,413.80
13,812.00
Liabilities & Shareholders' Equity
4,771.40
4,566.30
4,430.00
4,207.90
3,884.20
Preferred Stock (Carrying Value)
60.70
60.70
60.70
60.70
60.70
About Calmare Therapeutics
View Profile
